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Printing three-dimensional tissue analogues
with decellularized extracellular matrix bioink
Falguni Pati1,*, Jinah Jang2,3,*, Dong-Heon Ha1, Sung Won Kim4,5, Jong-Won Rhie6, Jin-Hyung Shim7,
Deok-Ho Kim3,8,9 & Dong-Woo Cho1
The ability to print and pattern all the components that make up a tissue (cells and matrix
materials) in three dimensions to generate structures similar to tissues is an exciting prospect
of bioprinting. However, the majority of the matrix materials used so far for bioprinting cannot
represent the complexity of natural extracellular matrix (ECM) and thus are unable to
reconstitute the intrinsic cellular morphologies and functions. Here, we develop a method for
the bioprinting of cell-laden constructs with novel decellularized extracellular matrix (dECM)
bioink capable of providing an optimized microenvironment conducive to the growth of
three-dimensional structured tissue. We show the versatility and ﬂexibility of the developed
bioprinting process using tissue-speciﬁc dECM bioinks, including adipose, cartilage and
heart tissues, capable of providing crucial cues for cells engraftment, survival and
long-term function. We achieve high cell viability and functionality of the printed dECM
structures using our bioprinting method.
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T
he ability to print tissue analogue structures through
delivering living cells with appropriate material in a
deﬁned and organized manner, at the right location, in
sufﬁcient numbers, and within the right environment is critical
for several emerging technologies. These technologies include,
tissue-engineering scaffolds1,2, cell-based sensors3, drug/toxicity
screening4 and tissue or tumour models5. The concept of tissue or
organ printing, often described as bioprinting6, is essentially an
extension of the idea that uses additive manufacturing methods to
build complex scaffold structures via a layer-by-layer process7–10.
A crucial aspect of bioprinting is that the printing process must
be cytocompatible, as it requires the dispensing of cell-containing
media. This restriction reduces the choice of materials because of
the necessity to operate in an aqueous or aqueous gel
environment11,12. In extrusion-based printing, hydrogels that
are solidiﬁed through either thermal processes or post-print
cross-linking are being used for printing of cells to produce
diverse tissues ranging from liver to bone using materials
such as gelatin13, gelatin/chitosan14, gelatin/alginate15, gelatin/
ﬁbrinogen16, Lutrol F127/alginate17 and alginate18. However,
there are some concerns over the outcomes from these studies,
such as the use of harsh cross-linking agents, like
glutaraldehyde14. Elsewhere, osteogenic differentiation was not
prominent on alginate gel and no differentiation was observed on
Lutrol F127 (ref. 17). In addition, when alginate gel was used for
printing of a cell-printed structure, only a minor fraction of cells
in the construct could differentiate towards osteogenic lineage17.
Normally, cells remain located speciﬁcally in their original
deposited position during the whole culture period, as they are
unable to adhere or degrade the surrounding alginate gel
matrix19. This limited interaction between the cells within the
gel can be explained by the noninteractive nature of alginate.
Thus, although there were some successful reports about
bioprinting of cell-printed structure, minimal cells–material
interactions and inferior tissue formation are the foremost
concerns.
Actually, these materials cannot represent the complexity of
natural extracellular matrices (ECMs) and thus are inadequate to
recreate a microenvironment with cell–cell connections and
three-dimensional (3D) cellular organization that are typical of
living tissues. Consequently, the cells in those hydrogels cannot
exhibit intrinsic morphologies and functions of living tissues
in vivo. It is thus ideal if cells are provided the natural
microenvironment similar to their parent tissue. Decellularized
extracellular matrix (dECM) is the best choice for doing so, as no
natural or man-made material can recapitulate all the features of
natural extracellular matrix (ECM)20. Moreover, ECM of each
tissue is unique in terms of composition and topology, which is
generated through dynamic and reciprocal interactions between
the resident cells and microenvironment21. Recent studies of cells
and ECM isolated from tissues and organs highlight the necessity
of tissue speciﬁcity for preserving selected cell functions and
phenotype20,22–25. The dECM materials are harvested and
typically processed as two-dimensional (2D) scaffolds from
various tissues, including skin26, small intestinal submucosa27,
where at the initial stages the inﬁltrating or seeded cell
populations depend on diffusion of oxygen and nutrient for
their survival until a supporting vascular network develops.
However, printing tissue analogue structures requires a
fabrication approach to devise a highly open porous 3D
structure to allow the ﬂow of nutrients11,28. Organ trans-
plantation in an orthotopic location is considered as a deﬁnitive
treatment for end-stage organ failure23,24,29. However, the
demand for transplantable organs surpasses the number of
available donor organs, compelling the manufacture of tissue or
organs to address this unmet demand.
Here we develop a bioprinting method for printing of cell-
laden structure with novel dECM bioink capable of providing an
optimized microenvironment conducive to the growth of 3D
structured tissue, where the intrinsic cellular morphologies and
functions can be reconstituted. We show the versatility and the
functionality of our bioprinting process using various types of
dECMs bioinks, including adipose, cartilage and heart tissues. As
applications of these functional cell-printed constructs, we
observe higher-order assembly of these cellular constructs with
organized spatial patterns and tissue-speciﬁc gene expression. A
key advantage of this methodology is the application of tissue-
speciﬁc ECM, providing crucial cues for cells engraftment,
survival and long-term function.
Results
Preparation of dECM bioink. The method for printing of cell-
laden construct using dECM bioink consists of a few steps
(Fig. 1). Decellularization of the ECM material is the initial step
and practically, the goal is to maximize the removal of cellular
material, while minimizing ECM loss and damage30. We
successfully decellularized the adipose (adECM), cartilage
(cdECM) and heart (hdECM) tissue after harvesting with a
combination of physical, chemical and enzymatic process using
slightly modiﬁed methods described elsewhere31–33. Furthermore,
0.1% peracetic acid solution in combination with 4% ethanol was
used in the last step of the decellularization method, which is
frequently considered as a disinfection step34. Efﬁciency of
decellularization method was evaluated through DNA
quantiﬁcation assay and was found to be optimal for removing
the cellular contents with B98% reduction and only 39±15,
11±1 and 6.7±1.2 ng of DNA per mg of tissue remaining in the
dECM of fat, cartilage and heart tissue, respectively (Fig. 2).
Hematoxylin and eosin (H&E) staining conﬁrmed the absence of
cells and cell debris in the matrix after decellularization (Fig. 2b,c)
in all samples of dECMs, including those from the innermost
regions of the processed tissues. Although the term
decellularization has not been deﬁned by quantitative metrics,
o50 ng dsDNA per mg ECM dry weight and lack of visible
nuclear material in H&E-stained tissue sections were reported to
satisfy the objective of decellularization30. Thus, it can be said that
we could effectively decellularize all the tissue samples.
Regrettably, xenogeneic ECM obtained from pig and other
animals may contain the Gala1,3Galb1,4GlcNAc-R (Gal) epitope,
which is a major factor in the hyperacute rejection of pig
organ transplants in primates35. However, Gal epitope within
porcine-derived ECM scaffold material was reported to elevate
the serum antibody level, but no adverse reaction upon tissue
remodelling was reported35. Thus, it is expected that dECMs used
in this study will not elicit any inﬂammatory reaction upon
implantation in a recipient. We also estimated the ECM
components, like collagen (COL) and glycosaminoglycans
(GAGs), before and after decellularization (Fig. 2d–f) with
hydroxyproline assay and dimethylmethylene blue assay,
respectively. The decellularization procedure adapted for heart
tissue caused no noteworthy loss of COL and GAGs (Fig. 2e). In
case of adipose tissue, the COL content increased slightly and the
GAGs content reduced moderately after decellularization
(Fig. 2f). As decellularization process removes all the cellular
components along with lipids from the adipose tissue, COL
contents seem to increase proportionately. For cartilage tissue, a
signiﬁcant loss of COL and GAGs were observed after
decellularization (Fig. 2d). The reason behind variation of the
proportion of ECM components was the difference of
decellularization processes adapted in this study30. Cartilage has
relatively denser ECM structure than that of heart, thus it requires
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more trypsinization and treatment with other enzymes, such as
deoxyribonuclease (DNAse) and ribonuclease (RNAse), to
remove all the cellular debris from ECMs. These enzyme
treatments may be responsible for the reduction of COL and
GAGs in decellularized cartilage tissue as trypsin treatment is
known to cause partial removal of ECM constituents30.
Unfortunately, the natural organization of structural ﬁbres is
lost by decellularization and reduction to a soluble powder and
advantages can be gained when other proteins (not identiﬁed)
were present in the extracts as shown by work of others36. We
have evaluated the presence of proteins or peptides through
sodium dodecyl sulphate (SDS)–PAGE (Supplementary Fig. 1),
which revealed the existence of various proteins within the
dECMs used in this investigation and in accordance with other
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Figure 2 | Decellularization of the native tissues and their biochemical analysis. Optical and microscopic images of native and decellularized (a) cartilage
tissue (scale bar, 50mm), (b) heart tissue (scale bar, 100mm), and (c) adipose tissue (scale bar, 100mm). ECM components (Collagen and GAGs) and
DNA contents of native and decellularized (d) cartilage (cdECM), (e) heart (hdECM) and (f) adipose (adECM) tissue. All experiments were performed in
triplicate. Error bars represent s.d. (*Po0.05; NS, no signiﬁcance).
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Figure 1 | Schematic elucidating the tissue printing process using dECM bioink. Respective tissues were decellularized after harvesting with a
combination of physical, chemical and enzymatic processes, solubilized in acidic condition, and adjusted to physiological pH. Tissue printing was performed
with the dECM bioink encapsulating living stem cells via a layer-by-layer approach followed by gelation at 37 C. The 3D cell-printed structure has
applications in various border areas including tissue engineering, in vitro drug screening and tissue/cancer model.
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studies37. Thus, the presence of various proteins and peptides will
ensure to gain the advantages by preparing cell-printed constructs
using dECMs bioink.
Central to our approach is the development of dECM bioinks
that can be extruded through the deposition nozzles in
ﬁlamentary form, which then undergo gelation at physiological
temperature and facilitates to retain the generated 3D structure.
For translating dECM to 3D printing system, the dECM was
solubilized to get a ﬁnal concentration of 3%. However, the
resulting solubilized dECM solution was acidic in nature and was
adjusted to physiological pH prior to encapsulating cells while
maintaining the temperature below 10 C. The pH-adjusted
dECM solution was designated as dECM pre-gel hereafter in this
study, which behaved like a heat sensitive material that remains in
the solution state at temperatures below 15 C and transforms to
gel when incubating at 37 C for 30min (Fig. 3a).
Characterization of dECM bioink. Rheological properties of pH-
adjusted dECM pre-gels were measured to evaluate their ﬂow
behaviour at temperatures below 15 C to mimic the condition for
printing. All dECM pre-gels showed shear thinning behaviour in
the measured shear rate range (Fig. 3b). In the case of extrusion
printing, one concern is the level of stress that cells endure during
printing processes. We calculated the shear rate generated during
the printing of dECM pre-gel and correlated it with the viscosity.
The generated shear rate in our printing method through a
250mm nozzle was determined in the range of 0.64–2.048 s–1. The
viscosities of the dECM solutions at 2 s 1 shear rate were 2.8 (for
cdECM), 6.13 (for adECM) and 23.6 Pa s 1 (for hdECM)
(Fig. 3b) when measured at 15 C, which is similar to the other
dECM gel reported in literature38. The storage and loss moduli of
the dECM pre-gels were measured at 15 C temperature that
exhibited more like a liquid mater. However, when rheological
properties were measured under oscillating condition after
incubating the dECM pre-gels at 37 C for 30min, they
behaved like a cross-linked gel and exhibited greater storage
modulus than loss modulus (Fig. 3d). Thus, after gelation, the
dECM gel can retain their shape and form, which is a prerequisite
for fabrication of cell-printed constructs.
In addition to the rheological properties, we also evaluated the
gelation kinetics of the dECM pre-gels at varying temperatures
starting from 4 to 37 C with a temperature ramp of 5 C and
holding at 15 C for 5min. As Fig. 3c shows, the complex
modulus started increasing soon after reaching the temperature
beyond 15 C and increased signiﬁcantly as the temperature
reached 37 C. This observation indicates that dECM pre-gels
started gelation immediately at temperature beyond 15 C and
formed a cross-linked gel at 37 C within 30min. Furthermore, it
is interesting to note that although the viscosities of the three
kinds of dECM pre-gels were similar; their storage moduli were
different from each other. Pre-gel cdECM revealed quite larger
storage modulus than those of the other two dECMs pre-gels
(adECM and hdECM). The protein concentration of the
ﬁnal dECMs is an important determinant of their rheological
properties as reported elsewhere34. Furthermore, the gelation
characteristics of the dECM solutions are not simply COL
chemistry but rather a result of the interplay of all of the
components within the digested ECMs34. The method of
decellularization also affects the rheological properties of ﬁnal
dECM solutions as the proportion of different components of the
dECM were shown to vary depending upon the decellularization
method adapted30. We have adapted different decellularization
procedure through optimization for adipose, cartilage and heart
tissue in this study, which possibly play a role in revealing
dissimilar rheological properties of the obtained dECM solutions.
Furthermore, the ratio and organization of various ECM
components also dictate the mechanical properties of the native
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Figure 3 | Rheological behaviour of the dECM pre-gels. Sol to gel transition (a) of the dECM pre-gels prepared from cartilage dECM (cdECM), heart
dECM (hdECM) and adipose dECM (adECM). Rheological properties of the dECM pre-gels (b) viscosity at 15 C, (c) gelation kinetics from 4 C
to 37 C. (Initial temperature: 4 C, increment of 5 Cmin 1 with holding at 15 C for 5min, reaching to 37 C, and maintaining 37 C for 40min), and
(d) dynamic modulus at varying frequency at 37 C. All experiments were performed in triplicate. Error bars represent s.d.
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tissues like cartilage having a larger storage modulus than that of
adipose or heart tissue. The native environment of tissue
determines the cellular function and fate. Thus, we could
assume that the cross-linked dECM gels from speciﬁc tissues
will support their resident cells adequately. Cells in the
adECM samples require a softer gel to mimic their natural
environment for acquiring their inherent phenotype. On the
other hand, chondrocytes require a favourable environment for
obtaining their rounded shape with prominent curvature of the
nucleus.
Printing of cell-laden structure using dECM bioink. The
essential process to produce a functional tissue is a fabrication of
dECM construct, allowing the encapsulating cells to migrate and
connect to each other three dimensionally. We successfully pro-
duced 3D open porous structures of dECMs with poly-
caprolactone (PCL) framework using a multi-head tissue/organ
building system (MtoBS) (Fig. 4a and Supplementary Fig. 2)
based on the 3D printing technique developed in house39. The
MtoBS is capable of positioning one or more polymer or hydrogel
or both at speciﬁc locations. We have applied different strategies
for fabricating dissimilar tissue constructs. For heart tissue
constructs, we have printed only the hdECM pre-gel without
any synthetic polymer supporting framework (Fig. 4a,b and
Supplementary Fig. 2b). On the other hand, we printed cartilage
and adipose tissue construct by depositing the cell-laden dECM
pre-gel following fabricating of PCL framework (Fig. 4a,c,d).
However, we opted for two separate line width of the PCL
framework, like 200mm was chosen for cartilage tissue that needs
more load-bearing support. For adipose tissue construct, we have
selected ﬁner line width, that is, 100 mm to reduce the stiffness. To
elaborate the process of fabricating hybrid structure, we have ﬁrst
laid down a layer of PCL framework followed by the positioning
of dECM pre-gel in every alternating gap between PCL lines to
make the porous structure (Fig. 4a, Supplementary Fig. 2 and
Supplementary Movie 1). The process was repeated for every
layer to produce the 3D construct. Thermal effect of PCL on cell
viability has already been veriﬁed in the previous work and found
to cause no/insigniﬁcant cell death8. One concern of printing
constructs with the hybrid approach using PCL is that this would
alter the overall cell environment, especially at the border of
dECM-PCL. A few cells present at the boarder of dECM-PCL
may experience the PCL environment, which is signiﬁcantly
stiffer than the cdECM40; however, majority of the cell will
experience the dECM surroundings as the cells were encapsulated
within the dECM gel prior to printing.
We fabricated the desired 3D microperiodic structure by
placing the cell-laden dECM pre-gel in between the PCL
framework on a warm stage. The dECM pre-gel was maintained
a hdECM
gel structure
Hybrid of cdECM
and PCL framework
PCL framework
(moderate, wide)
cdECM gel adECM gelhdECM gel
PCL framework
(fine)
Hybrid of adECM
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Figure 4 | Printing process of particular tissue constructs with dECM bioink. (a) Heart tissue construct was printed with only heart dECM (hdECM).
Cartilage and adipose tissues were printed with cartilage dECM (cdECM) and adipose dECM (adECM), respectively, and in combination with PCL
framework (scale bar, 5mm). (b) Representative microscopic images of hdECM construct (scale bar, 400mm), (c) s.e.m. images of hybrid structure of
cdECM with PCL framework (scale bar, 400mm) and (d) microscopic images of cell-printed structure of adECM with PCL framework (scale bar, 400mm).
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at temperatures below 15 C during its extrusion from syringe.
The cell-printed structure was gelled in a humidiﬁed incubator at
37 C for 30min. The printed gel remained stable on the
deposited position throughout the culture period without
separation for at least 14 days (Fig. 5a–c and Supplementary
Fig. 3). Furthermore, the system is capable of fabricating
structures with various geometries needed for certain tissues.
Using our bioprinting process, we successfully printed structures
from 1 to 10 layers, as shown in Fig. 4a. Thus, it is not
overwhelming to state that we can print constructs from thin to
thick dimensions via proper positioning of this novel bioink
encapsulating cells with engineered porosity for nutrient
and oxygen supply depending on the requirements. We also
observed the versatility of this method through printing two
kinds of bioinks from different dECMs in a single construct
(Supplementary Movie 2), which could enable us to fabricate
composite tissues.
For printing of cell-laden dECM pre-gel, one important
criterion is that the material should come out of the nozzle with
minimum applied shear force. Otherwise, the applied shear force
may cause damage to the cells and reduce the cell viability in the
printed constructs11. We have checked the cell death that may
take place by the generated shear stress through TUNEL assay
that is capable of detecting the apoptotic cells. Shear rate of 2 s 1
was chosen to simulate the printing process. As it can be seen in
Fig. 5d, there was very minimal cell death caused by the printing
process and no difference in number of apoptotic cells were found
in printed construct and the gel without printing. To obtain a
desired cell number and cell distribution in the construct, higher
cell viability of the printed construct should be maintained. The
cell viability in the printed construct was found to be sufﬁciently
high (495%) when examined after 24 h (Fig. 5e). Cell-printed
structure with only hdECM also revealed similar result of high
viability of myoblasts after 24 h (Supplementary Fig. 4). Actually,
dECM gels possibly protect the cells through cushioning them
during extrusion and allow cells to acquire the desired
morphology during their residence in the gel. We also could
observe the cell- to -cell connections in 3D within 24 h mimicking
the in vivo conditions (Fig. 5e), which is very important for their
survival and functions. Moreover, the dECM gels did not produce
any deleterious effect on the cells or hindered their migration
as the high cell viability (490%) was maintained when the
sample was examined on day 7 and 14 with active cell
proliferation (Fig. 5e).
Tissue-speciﬁc gene expression. We investigated cellular
morphologies and functions of the cell-laden constructs using
stem cells, such as human adipose-derived stem cells (hASCs) and
human inferior turbinate-tissue derived mesenchymal stromal
cells (hTMSCs), a potential abundant cell source for clinical
application from human inferior turbinate tissues generally dis-
carded during turbinate surgery41,42. These cells have been shown
to be promising for adipose tissue regeneration25 and cartilage
tissue regeneration41, respectively. To assess the differentiation of
the printed stem cells, in particular encapsulating in dECM,
tissue-speciﬁc gene expressions were analysed. Before
demonstrating the superiority of each dECM material, cell
proliferation test was conducted. This test veriﬁed that all the
dECMs provide biocompatible microenvironment for cell
proliferation and outperformed the other printable materials,
such as COL and alginate (Supplementary Figs 5 and 6). Among
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Figure 5 | Long-term stability and cellular compatibility of the printed tissue constructs. Representative images of the whole constructs prepared
with hdECM (a) and adECM (b) at progressing days of cell culture (scale bar, 2mm). Confocal image of the whole construct prepared with adECM at day
14 of culture (c) showing live cells (green dots) and dead cells (red dots) (scale bar, 2mm). An image of the whole construct was reconstructed
from B32 images taken at different positions. Representative images of apoptosis through TUNEL (d) and Live/Dead (e) assays (scale bar, 100mm).
TUNEL assay displays very minimal apoptotic cells, which suggests that the generated stress at 2 s 1 shear rate at the nozzle wall did not cause
deleterious effect on the encapsulated cells and resulted similar apoptosis to the non-printed gel (0 s 1). Cell viability was 495% at day 1 and 490%
at both day 7 and 14.
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the various ECM components, COL was selected as a control for
comparative analysis of target gene expression, because it is the
most abundant component of ECM and has been used for cell
printing43. Although, the major COL of cartilage is type II COL,
not type I, we chose it as a control because of its increased
application in cartilage tissue engineering. Direct differentiation
of hTMSCs into chondrogenic lineage in cdECM was veriﬁed
through qRT–PCR analysis. We normalized the target genes
expressions with glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), as it shows least variation when cells were cultured
on TCP over time (Supplementary Fig. 7). On day 14, cells
printed with cdECM revealed greater messenger RNA (mRNA)
expressions of SOX9 that is an early chondrogenic transcription
factor and type II COL than that of COL construct (Fig. 6a).
Moreover, on day 3, SOX9, adhesion-related genes (focal
adhesion kinase; protein tyrosine kinase 2) and integrin b1
were signiﬁcantly greater than that of COL (Supplementary
Fig. 8), indicating the chondrogenic potential of cdECM
constructs. Rat myoblast cells (L6, ATCC CRL-1458) were used
to verify the effectiveness of hdECM for functional maturation of
myoblasts. For assessment of the maturation level of myoblast in
the hdECM structure, mRNA expression was analysed through
qRT–PCR; in particular, the expression level of cardiac-speciﬁc
genes like fast myosin heavy chain (Myh6) and alpha-sarcomeric
actinin (Actn1). The hdECM constructs disclosed signiﬁcantly
higher levels of both the genes than that of the COL constructs
during 14 days study period (Fig. 6b). Moreover, the expression of
Myh6 and Actn1 were also higher in hdECM than that of COL at
day 4 and 7 (Supplementary Fig. 9), which signify the superiority
of hdECM over COL gel.
Adipogenic differentiation has been shown to enhance
under high-density conditions where the cells have a more
rounded morphology and the cellular growth ceases44. As such,
the high-density cell printing is an important step that will
facilitate adipogenic differentiation for supporting adipogenesis in
the culture groups. We have shown the possibility of printing cell-
laden construct with high density (5 106 cellsml 1) using our
bioprinting method without any deleterious effect on cell
viability. Moreover, a signiﬁcant increase in the expression of
the master adipogenic regulators peroxisome proliferator-
activated receptor gamma (PPARg) and CCAAT/enhancer-
binding protein alpha (C/EBPa) together with an increase in
early adipogenic marker lipoprotein lipase (LPL) was observed
when hASCs were cultured in adECM in comparison with COL
and alginate (Fig. 6c and Supplementary Fig. 10), widely used
materials for cell printing2,18. The gene expression trends in the
constructs showed increase in the expression of the adipogenic
markers over time, consistent with a progression in
differentiation, demonstrating the ‘adipoconductive’ nature of
adECM. Thus, 3D printed constructs fabricated through our
bioprinting method using dECM bioink supported differentiation
and maturation of encapsulated cells and functionality of the
respective tissues.
Tissue formation. Tissue formation was evaluated through
immunohistological study. Supportive role of cdECM to differ-
entiate hTMSCs into the chondrogenic lineage in cell-printed
constructs with cdECM was veriﬁed through immuno-
ﬂuorescence imaging, which indicated that the cells synthesized
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Figure 6 | Evaluation of differentiation into tissue-speciﬁc lineages and structural maturation of cells. Comparative gene expression analysis
for (a) chondrogenic (SOX9 and COl2A1), (b) cardiogenic (Myh6 and Actn1) and (c) adipogenic (PPARg and LPL) in COL and particular dECM (cdECM or
hdECM or adECM) at day 14. Immunoﬂuorescence images showing chondrogenic differentiation of hTMSCs in (d) COL and (e) cdECM constructs showing
COL type II staining (COLII, red), cell nuclei (DAPI, blue) and F-actin (green) (scale bar, 50mm). Structural maturation of myoblasts in (f) COL and (g)
hdECM construct showing Myh7 (red) and cell nuclei (DAPI, blue) (scale bar, 200mm). Adipogenic differentiation of hASCs in (h) COL and (i) adECM
constructs showing PPARg (red), COL IV (green) and cell nuclei (DAPI, blue) (scale bar, 50mm). All experiments were performed in triplicate. Error bars
represent s.d. (*Po0.05).
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type II COL within the construct (Fig. 6d,e and Supplementary
Fig. 11) and was in accordance with the mRNA expression
results. We also veriﬁed the function of cdECM on enhancing cell
adhesion by using F-actin staining (Fig. 6e). Most of the cells
displayed spread morphology on the TCP (Supplementary
Fig. 12a) and COL (Supplementary Fig. 12b); on the other
hand, many cells were migrated into the depth of the cdECM
(Supplementary Fig. 12c) and the cells were observed to be
elongated and created mesh-like junctions in between them. This
phenomenon corresponds to the expression of adhesion-related
genes. It is also implied that cdECM have abundant residues to
bind cells, which might have triggered the chondrogenesis tran-
scription marker like SOX9 (Supplementary Fig. 8). The
maturation of myoblasts in cell-printed structure with hdECM
was investigated by cardiac myosin heavy chain (b-MHC)
staining and was compared with that of COL (Fig. 6f,g and
Supplementary Fig. 13), an abundantly available protein in the
myocardium. The result showed that cells expressed higher level
of b-MHC in the hdECM construct than that of COL and was
also in accordance with the qRT–PCR result. In general, myo-
blasts were formed into the myoﬁbres during the structural
maturation. Subsequent to this, the differentiated myoblasts
(myocytes) express the slow myosin heavy chain and synchronize
with the native tissue. The slow myosin heavy chain is usually
expressed in the newly formed cardiomyocytes. This phenom-
enon is associated with the graft survival; especially, the enhanced
graft survival inﬂuences the alignment of the differentiated
myoblasts in parallel with the host myocardial ﬁbre45. The above
ﬁnding advocates the potentiality of myoblasts printed hdECM
structure for myocardial reconstruction. Upon differentiation of
hASCs into the adipogenic lineage, they express PPARg and COL
IV. Cell-printed construct with adECM revealed substantial
expression of PPARg and COL IV (Fig. 6h,i, and Supplementary
Fig. 14) with higher level of ﬂuorescence intensity to that of COL
construct. These observations highlight the tissue-formation
capabilities of our cell-printed constructs.
Discussion
In the present study, for the ﬁrst time, tissue printing with
particular dECM bioink that encompass either living hASCs or
hTMSCs is demonstrated. Printed cell dECM constructs revealed
higher levels of cell viability, differential lineage commitment and
ECM formation. This study addresses recent advancement in the
ﬁeld of bioprinting for engineering biological tissues, consisting of
cells encapsulated in dECM with speciﬁc organization and matrix
composition. The adapted printing technology of depositing cell-
laden dECM hydrogel that we used can fulﬁl several important
requirements of tissue-engineered grafts, including tissue-speciﬁc
matrix materials, engineered interconnected porosity, the intro-
duction of pertinent cells, and the opportunity to explore
organizational aspects in tissue regeneration. Encapsulation of
cells within dECM hydrogel prior to the deposition process
facilitates the formation of cell-laden, viable printed constructs17.
In this way, the cell loading can be altered and different types of
cells can be laid down in tissue-mimicking architectures. We have
also shown that our printing method does not cause stress-
induced apoptosis of the encapsulated cells and high level of cell
viability was achieved. Moreover, being a robust dispensing
method, our bioprinting technique can produce constructs of
anatomically relevant (centimetre scale) sizes for tissue
replacement.
Pepsin digestion cleaves the telopeptide regions of the COL,
which allows solubilization of the dECM in dilute acids43. We
could achieve highly concentrated dECM solution with adequate
viscosity for printing of cell-laden constructs. When pH values of
these dECM solutions were adjusted, they behaved similar to
temperature-sensitive pre-gel materials, allowing printing of well-
deﬁned 3D constructs that were transformed into physically
cross-linked gel at 37 C. The structures were stable in vitro
without the need for chemical cross-linking. We used dECMs
processed from tissues, such as adipose, cartilage and heart, for
printing of particular tissue analogue. Likewise, this method can
also be extended to ECM from other tissues with little
modiﬁcation. At present, tissue-engineering strategies utilizing
ECM materials are being successfully used clinically for the
regeneration of a range of tissues46,47. The main advantage of
utilizing ECM material is that it facilitates constructive
remodelling at the implantation site and encourages speciﬁc
tissue formation rather than forming inferior and less functional
scar tissue36.
We demonstrated that human living progenitor cells survive
the generated shear stress during the printing process of cell-
laden dECM hydrogel with a high level of cell survival, which is in
line with previous reports17. This can be explained through the
shear thinning behaviour of ECM hydrogel, which results in a
decrease in shear stress. This phenomenon of shear thinning is a
common behaviour for polymeric gel or hydrogel and has been
described in detail elsewhere48. We could print a precisely deﬁned
but ﬂexible designed structure with a homogenous distribution of
cells within the construct. In addition, to improve the mechanical
integrity of the printed dECM hydrogel constructs, cell-laden
hydrogels were combined with structurally stiffer synthetic
polymers, such as PCL for cartilage construct. The versatility of
of our bioprinting method was demonstrated through printing
two different bioinks from various dECMs in a single constructs.
The capability to print different dECM hydrogels simultaneously
exempliﬁed the ability of our process to reproducibly print
heterogeneous 3D structures comprising various kinds of dECM.
As a follow-up step, we demonstrated the printing of
heterogeneous constructs (that is, printed with different kinds
of dECM at different locations). However, further studies should
be directed to investigate the heterogeneous tissue formation
based on this approach.
The ECM microenvironment plays a fundamental role in
directing and mediating the differentiation of stem cell while
culturing them49. There is strong evidence supporting that this
instruction conveyed through both receptor ligand interactions,
as well as mechanical signalling events, which in turn stimulate
the important signal transduction pathways and control the
cellular function49. The cell–ECM interactions are extremely
complex in nature and justify the need for a tissue-speciﬁc
approach while creating the native stem cell niche. Recent studies
have validated this tissue-speciﬁc outlook and shown the
manifestation of enhanced functions20 and intricate tissue
formation22,23 when site-speciﬁc ECM scaffolds were being
employed. The ECM scaffolds were shown to have the capacity
to direct tissue-speciﬁc stem cell lineage commitment and
maintaining the phenotype of mature cell populations50. Here,
we obtain a synergistic effect through combining the beneﬁcial
effects of dECM with tissue printing process to get a cell-laden
construct with engineered porosity in a tissue-speciﬁc manner.
With this approach, we were able to generate a tissue analogue
in vitro with either adipogenic or chondrogenic potential. In
particular, we demonstrated that hASCs or hTMSCs could be
printed via encapsulating in dECM pre-gel and that the in vitro
culture did not modify cell survival and proliferation, but
increased the commitment of stem cells towards either
adipogenic lineage within dECM from fat tissue or
chondrogenic lineage within cartilage dECM. Enhanced
structural maturation of myoblasts was observed in constructs
prepared with dECM from heart tissue. ECM has been shown to
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guide tissue morphogenesis through modulating cell–cell
interactions51,52. Thus, we demonstrated that tissue printing
with dECM bioink is an attractive option that opens up new
avenues for both in vitro and in vivo tissue reconstruction.
Nevertheless, there are other potential application areas where a
tissue analogue structure developed by our bioprinting method is
worthwhile (Fig. 1). In vitro models of human physiology and
pathology can be developed using our bioprinting method and
can beneﬁt to convincingly and accurately predict the outcomes
of in vivo drug administrations and potential toxic exposures, if
any4. Furthermore, cancer model can be developed by recreating
the microenvironmental characteristics representative of tumours
in vivo with our bioprinting method with dECM that provide
cancer tissue-mimicking 3D environment5.
Methods
Materials. As synthetic biomaterial, FDA-approved PCL (molecular
weight¼ 70,000–90,000 gmol 1; Polyscience, Inc., PA, USA) was used. SDS
solution 10% and 1M Tris-HCL solution were purchased from Bioneer, South
Korea. Triton X-100 was purchased from Affymetrix-USB, Santa Clara, CA.
Pepsin, DNAse and RNAse A were purchased from Sigma-Aldrich, St Louis, MO.
Sodium chloride (NaCl) was purchased from Junsei, Japan. Unless otherwise sta-
ted, cell culture reagents were obtained from Sigma-Aldrich.
Decellularization of tissues. Porcine cartilage and heart from a 6-month-old pig
was collected from a nearby slaughter house and used with approval from the
supplier. The left ventricle was isolated from the whole porcine heart. Heart tissue
decellularization was conducted by following the protocol published elsewhere with
slight modiﬁcation32. Tissues were cut into pieces of about 1mm in thickness. The
chopped heart tissue was stirred in 1% SDS in phosphate-buffered saline (PBS)
solution for 48 h followed by treatment with 1% Triton X-100 solution for 30min.
The decellularized heart tissue was washed using PBS at least for 3 days.
The hyaline cartilage was collected from porcine articular cartilage and
decellularized by following the protocol published elsewhere with modiﬁcation33.
Brieﬂy, the minced cartilage was placed into a hypotonic Tris-HCL buffer solution
(10mM Tris–HCL, pH 8.0) and 6 cycles of freezing (at  80 C) and thawing (at
37 C) were conducted. The cartilage slurry was homogenized and treated with
0.25% trypsin in PBS for 24 h at 37 C with vigorous agitation. The trypsin solution
was replaced with the fresh one at every 4 h. Trypsinized cartilage slurry was
washed with a hypertonic buffer solution (1.5M NaCl in 50mM Tris-HCL, pH 7.6)
and treated with nuclease solution (50Uml 1 DNAse and 1Uml 1 RNAse A in
10mM Tris–HCL, pH 7.5) with gentle agitation at 37 C for 4 h. To remove all the
enzymes, the enzyme-treated cartilage slurry was washed with the hypotonic
Tris–HCL solution for 20 h following treatment with 1% Triton X-100 solution for
24 h. The decellularized cartilage tissue was washed at least for 3 days to remove all
the detergent.
The adipose tissue was collected from hospital (St Mary’s Hospital, Seoul, South
Korea) after liposuction of seven different female donors at the ages between 35
and 54 with informed consent and under approval from the Catholic University of
Korea Institutional Review Board. The collected tissue was centrifuged to separate
the oil and blood from the tissue. The adipose tissue was washed with PBS solution
and decellularized with 0.5% SDS solution for 48 h with changing the solution
every 12 h. Decellularized adipose tissue was then treated with isopropanol to
remove the lipid for 48 h with changing the isopropanol every 12 h followed by
washing several times with PBS solution. Finally, all the decellularized and
delipidated tissues were treated with a solution of 0.1% peracetic acid in 4% ethanol
for 4 h followed by washing several times with PBS solution and distilled water. The
obtained dECMs from heart, cartilage and adipose tissues were lyophilized and
stored in  20 C freezer.
Biochemical characterization of dECMs. To verify the extent of decellularization,
the residual DNA was measured and histological sections were analysed with H&E
staining. ECM components like COL and GAGs in the decellularized tissue were
also assessed. For DNA quantiﬁcation, all the dECMs were digested in 1ml of
papain solution (125 mgml 1 papain in 0.1M sodium phosphate with 5mM Na2-
EDTA and 5mM cysteine-HCl at pH 6.5) for 16 h at 60 C. Papain solution
without sample for using as a diluent in biochemical assays was also incubated.
Native tissues of similar weight were also digested in a same manner as controls.
The DNA content was determined using Hoechst 33258 assay53. The ﬂuorescence
intensity was measured to assess the amount of remaining DNA within the dECMs
and the native tissue using a ﬂuorescence spectrophotometer (TECAN,
Switzerland; excitation wavelength: 360 nm, emission wavelength: 450 nm). The
standard curve for DNA was generated in advance using calf thymus DNA and
used for quantifying the DNA in samples.
For histological evaluation, both native and decellularized tissues were ﬁxed in
4% formalin, washed several times with distilled water, embedded in OCT
compound, sectioned using a cryotome (Leica CM1850 Cryostat, Germany),
stained with H&E, and observed under microscope.
The GAGs content was estimated via quantifying the amount of sulphated
glycosaminoglycans using 1,9-dimethylmethylene blue solution54. The absorbance
was measured with microplate reader at wavelength of 492 nm. The standard curve
was made using chondroitin sulphate A in advance and used for estimating the
sulphated glycosaminoglycans in samples. The total COL content was determined
via a conventional hydroxyproline assay55. The absorbance of the samples was
measured at 550 nm and quantiﬁed by referring to a standard curve made in
advance with hydroxyproline.
Preparation of dECM solution and pre-gel. Lyophilized dECM was crushed into
powder using a mortar and pestle with the help of liquid N2. Required amount of
dECM powder was weighed and digested in a solution of 0.5M acetic acid with
10mg of pepsin for 100mg dECM (P7125, Sigma-Aldrich) for 48 h. After complete
solubilization of dECM, the solution was centrifuged (only for adipose dECM) to
remove the particulate things if any and used for further examinations. The pH of
dECM solution was in the range of 2.8–3. The pH was adjusted with dropwise
addition of cold 10M NaOH solution while maintaining the temperature below
10 C to avoid gelation of the dECM. The pH-adjusted dECM pre-gel was stored in
refrigerator at 4 C.
Rheological characterization. Rheological investigations were conducted on an
Advanced Rheometric Expansion System (TA Instrument, USA) using 25mm
diameter plate geometry. To assess the viscosity, steady shear sweep analysis of
various dECM pre-gels were performed at a constant temperature of 15 C.
Dynamic frequency sweep analysis was conducted to measure the frequency-
dependent storage (G0) and loss (G00) moduli of various dECM gels in the range of
1–1,000 rad s–1 at 2% strain after incubation for 30min at 37 C. A temperature
sweep was used to study the gelation kinetics of dECM pre-gels. The complex
modulus was measured at each temperature while the dECM pre-gels were sub-
jected to a temperature ramp in the range of 4–37 C with a increment rate of
5 Cmin 1. In addition, at 15 C, the dECM pre-gels were held for 5min. All
measurements were conducted in triplicate.
Cell encapsulation in the dECM pre-gel. hASCs and hTMSCs were used for
assessment of the effectiveness of adECM and cdECM on adipogenic and chon-
drogenic differentiation of adult stem cells, respectively. The cells were isolated and
cultured by a previously described method41,42,56. Rat myoblast cells (L6, ATCC
CRL-1458) were used for verifying functional enhancement of myoblasts in the
hdECM. hASCs and L6 cells were cultured in the DMEM high glucose
supplemented with 10% fetal bovine serum and 1% antibiotics (penicillin/
streptomycin), and hTMSCs were cultured in the aMEM supplemented with 10%
fetal bovine serum and 1% antibiotics (penicillin/streptomycin). All the cells used
were from passage 2 to 5. Cultured cells were detached from the tissue culture plate
with 0.25% trypsin solution, centrifuged at 1,500 r.p.m. for 3min, suspended in
fresh media and counted. To maintain the same osmotic pressure, 10
concentrated culture media was added to the pH-adjusted dECM pre-gel (1/10th
volume) and the suspended cells were mixed thoroughly with the pH-adjusted
ECM pre-gel. The concentration of cells used was from 1 to 5 106 cellsml 1.
All processes were conducted on ice. The prepared bioink was loaded in a sterilized
syringe for cell printing.
Printing of cell-laden construct. A MtoBS, a bioprinting system developed in our
lab, with six different syringe holders and capable of simultaneously dispensing six
different materials, was used for printing of cell-laden construct. PCL was loaded in
a syringe and heated to 80 C to melt the polymer. The dECM pre-gel encapsulated
cells were loaded to the other syringe and maintained at temperatures below 15 C.
Cell-printed constructs were fabricated according to the method described else-
where39. We used two syringes for constructing each structure, one containing PCL
and maintained at 80 C, the other one loaded with cell-laden pre-gel and
maintained at temperatures below 15 C. The applied pneumatic pressure was in
the range of 400–650 kPa for fabrication of the PCL framework. The cell-laden pre-
gel was dispensed using a plunger-based low-dosage dispensing system. In the
process of printing synthetic polymer, temperature of the molten PCL comes down
very fast in the air gap before reaching the stage.
Cell viability and apoptosis test. Cells were under a relatively high shear-stressed
environment when the mechanical perturbations were applied to the cells by dis-
pensing bioinks. Therefore, we veriﬁed the viability and apoptosis of cells after the
printing. For cell apoptosis assay, we selected hdECM as a representative bioink
due to its highest viscosity among the developed bioinks. The hTMSCs were
encapsulated at a concentration of 5 105 cellsml 1 into 3% hdECM pre-gel and
the prepared bioink was loaded into the piston syringe. The grid type structure of
100 mm in thickness was fabricated with the hdECM bioink at 2 s 1 shear rate,
which was selected to simulate the shear rate generated during printing. Finally, the
fabricated structure was cross-linked by incubating at 37 C temperature for
30min. After 24 h of incubation in the complete medium, the structure was ﬁxed
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by 4% paraformaldehyde and treated with the DeadEnd Fluorometric TUNEL
System kit (Promega, WI) following manufacturer’s protocol with little modiﬁca-
tion. We treated all reagents for a longer time than that of the time mentioned in
the protocol due to the larger thickness of the structure. The TUNEL system can
measure the fragmented DNA of apoptotic cells by catalytically binding ﬂuor-
escein-12-dUTP; thus, the ﬂuorescein-12-dUTP-labelled DNA in the fabricated
structure was visualized by confocal microscope (Olympus FluoView FV1000,
Tokyo, Japan). Cell nucleus was counterstained by DAPI (GBI Labs, WA). To
conduct viability test, cell-printed structures with dECM was evaluated by staining
with live and dead assay kit (LIVE/DEAD Cell Viability Assays, Invitrogen Life
Technologies, USA) following manufacturer’s protocol.
Gene expression analysis through RT–PCR. After culturing the constructs for
the speciﬁed time period, total RNA of cells was isolated using TRIzol reagent
(Invitrogen Life Technologies, USA) following the manufacturer’s protocol. RNA
concentration was measured using a Nanodrop (Thermo Scientiﬁc, USA). Reverse
transcription was performed with the cDNA synthesis kit (Thermo Scientiﬁc, USA)
following manufacturer’s instructions. Gene expression was analysed quantitatively
with SYBR-green using 7500 Real-Time PCR system (Applied Biosystems, Life
Technologies, USA). The primers and probes for collagen type II (COL2A1), SOX9,
protein tyrosine kinase 2, Integrin b1, PPARg, C/EBPa, LPL, Myh6, Actn1,
beta-actin, 18S ribosomal RNA and GAPDH were designed on the basis of pub-
lished gene sequences (NCBI and PubMed). We checked the expression patterns of
various endogenous control genes (GAPDH, beta-actin and 18S ribosomal RNA) of
cells cultured on TCP over time. GAPDH has shown low level of variance among
samples over time than the other genes (Supplementary Fig. 7). Thus, we have
chosen GAPDH as an endogenous control for our study. Expression levels for each
gene were normalized with GAPDH and analysed using the 2DDCT method.
Each sample was assessed in triplicate.
Immunohistological study. The cell-printed structure was harvested and ﬁxed
with a solution of 4% paraformaldehyde after 14 days culture. The structure was
embedded in OCT compound and sectioned using cryotome in 10-mm thickness.
The sliced samples were washed repeatedly with PBS solution to remove OCT
compound and then permeabilized with a solution of 0.1% Triton X-100 in PBS for
5min. To reduce non-speciﬁc background, sections were treated with 0.2% bovine
serum albumin solution in PBS for 20min. For visualization of differentiation and
maturation of stromal cells to chondrogenic cells, sections were immunostained
using primary antibody against anti-collagen II antibody (1:100; Abcam, UK)
followed by incubation with Alexa Fluor 594 goat anti-mouse antibody (1:100;
Invitrogen, CA). Sections were also stained with phalloidin-FITC solution (1:100;
Sigma-Aldrich, MA) for 40min and DAPI for 15min. The adipogenic cell-printed
structure was harvested and ﬁxed with a solution of 4% paraformaldehyde after 14
days culture and stained following similar protocol using PPARg (1:100; Santa
Cruz Biotechnology Inc, Catalogue No. sc-81152) and Collagen IV (1:100; Santa
Cruz Biotechnology Inc, COL4A5 (H-234): sc-11360). Secondary antibody of Alexa
Fluor 594 goat anti-mouse antibody (1:100; Invitrogen, CA) and Alexa Fluor 488
goat anti-rabbit antibody (1:100; Invitrogen, CA) were used and counterstained
with DAPI. For detection of the myotube formation in the hdECM construct,
sections were stained with anti-heavy chain cardiac myosin antibody (1:100;
Abcam), followed by incubation with secondary goat anti-mouse-Alexa 594 anti-
body (1:100) and counterstained with DAPI. For F-actin expression analysis, the
cells were seeded on the each material (tissue culture plate, TCP; COL and cdECM
gel), and were cultured for 3 days and stained with phalloidin-FITC solution for
40min and DAPI for 15min. Stained samples were visualized and images were
captured using a confocal microscope.
Statistical analysis. All data are expressed as mean±s.d. All statistical analysis
was performed by using SigmaPlot software (ver. 10.0, Systat Software Inc., San
Jose, CA). Statistical signiﬁcance was determined by a one-way analysis of variance.
Differences were considered to be statistically signiﬁcant at Po0.05.
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